Or could be the opposite, and if targeting hedge funds and short sales, they may hit large funds like Citadel, and the OTC companies they have been the market maker for.
That is more manageable that targeting deep pocketed NYSE and NASDAQ firms.
Think about that approach, after all Citadel is the largest market maker in the OTC.
What is clear, let’s read everything coming out every day on the evolving regs and not focus on the past.
The amendments to the 15c2-11 affected the OTC and eliminated many companies who had been trading without providing current public information and acknowledged that DBMM was Pink Current.